ESC 365 - A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

ESC Premium Access

A novel role of SGLT2 inhibitors to increase circulating proangiogenic progenitor cells in patients with type 2 diabetes and cardiovascular disease: A sub-study of the EMPA-HEART CardioLink-6 Trial

Session: Insights into cardiac cell biology for repair and regeneration

Topic: Microcirculation, Angiogenesis, Arteriogenesis

Speaker: Ms D. Terenzi (Toronto, CA)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Ms Daniella Terenzi

St. Michael's Hospital, Toronto (Canada)

0 follower

6 more presentations in this session

ADGRL2 is an essential surface molecule for cardiac lineage specification and heart development

Speaker: Professor H. Cho (Seoul, KR)

Osteopontin stimulates cell cycle in neonatal cardiomyocytes

Speaker: Mr I. Rotem (Tel Aviv, IL)

In-vivo and vitro mitochondrial transfer from adipose-derived mesenchymal stem cell to ischemic cardiomyocyte

Speaker: Doctor D. Mori (Osaka, JP)

The cardiac endothelial cell transcriptome in neonatal, adult, and remodeling hearts

Speaker: Miss L. Dugaucquier (Antwerp, BE)

Exosomes mediate myocardial regeneration of cardiac progenitor cells in a swine model of dilated cardiomyopathy

Speaker: Doctor K. Hirai (Okayama, JP)

Access the full session

Insights into cardiac cell biology for repair and regeneration

Speakers: Ms D. Terenzi, Professor H. Cho, Mr I. Rotem, Doctor D. Mori, Miss L. Dugaucquier...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources